A detailed history of Met Life Investment Management, LLC transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 21,262 shares of PRME stock, worth $112,263. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,262
Holding current value
$112,263
% of portfolio
0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$6.35 - $9.39 $135,013 - $199,650
21,262 New
21,262 $148,000
Q3 2023

May 09, 2024

BUY
$9.5 - $15.07 $144,124 - $228,626
15,171 Added 249.07%
21,262 $202,000
Q2 2023

Apr 29, 2024

BUY
$11.41 - $17.05 $242,599 - $362,517
21,262 New
21,262 $311,000
Q2 2023

Aug 10, 2023

BUY
$11.41 - $17.05 $173,101 - $258,665
15,171 Added 249.07%
21,262 $311,000
Q1 2023

May 09, 2024

BUY
$11.21 - $21.11 $68,280 - $128,581
6,091 New
6,091 $74.9 Million
Q4 2022

May 10, 2024

BUY
$16.24 - $21.12 $98,917 - $128,641
6,091 New
6,091 $113,000
Q4 2022

Feb 15, 2023

BUY
$16.24 - $21.12 $98,917 - $128,641
6,091 New
6,091 $113,000

Others Institutions Holding PRME

About Prime Medicine, Inc.


  • Ticker PRME
  • Shares Outstandng 95,730,200
  • Market Cap $505M
More about PRME
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.